Variants of PNPLA3 polymorphisms were proven to be associated with NAFLD/NASH, together with the polymorphisms of the transmembrane 6 superfamily member 2 (TM6SF2) gene [21]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatohepatitis.